日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Recurrent somatic mutations of FAT family cadherins induce an aggressive phenotype and poor prognosis in anaplastic large cell lymphoma

FAT 家族钙粘蛋白的复发性体细胞突变导致间变性大细胞淋巴瘤出现侵袭性表型和预后不良

Matteo Villa, Geeta G Sharma, Federica Malighetti, Mario Mauri, Giulia Arosio, Nicoletta Cordani, Cosimo Lobello, Hugo Larose, Alessandra Pirola, Deborah D'Aliberti, Luca Massimino, Lucrezia Criscuolo, Lisa Pagani, Clizia Chinello, Cristina Mastini, Diletta Fontana, Silvia Bombelli, Raffaella Meneve

Integrated Genomic, Functional, and Prognostic Characterization of Atypical Chronic Myeloid Leukemia

非典型慢性粒细胞白血病的综合基因组、功能和预后特征

Diletta Fontana, Daniele Ramazzotti, Andrea Aroldi, Sara Redaelli, Vera Magistroni, Alessandra Pirola, Antonio Niro, Luca Massimino, Cristina Mastini, Virginia Brambilla, Silvia Bombelli, Silvia Bungaro, Alessandro Morotti, Delphine Rea, Fabio Stagno, Bruno Martino, Leonardo Campiotti, Giovanni Caoc

De novo UBE2A mutations are recurrently acquired during chronic myeloid leukemia progression and interfere with myeloid differentiation pathways

在慢性粒细胞白血病进展过程中,UBE2A 新发突变会反复发生,并干扰髓系分化途径

Vera Magistroni, Mario Mauri, Deborah D'Aliberti, Caterina Mezzatesta, Ilaria Crespiatico, Miriam Nava, Diletta Fontana, Nitesh Sharma, Wendy Parker, Andreas Schreiber, David Yeung, Alessandra Pirola, Sara Readelli, Luca Massimino, Paul Wang, Praveen Khandelwal, Stefania Citterio, Michela Viltadi, S

SETBP1 induces transcription of a network of development genes by acting as an epigenetic hub

SETBP1 通过充当表观遗传枢纽来诱导发育基因网络的转录

Rocco Piazza, Vera Magistroni, Sara Redaelli, Mario Mauri, Luca Massimino, Alessandro Sessa, Marco Peronaci, Maciej Lalowski, Rabah Soliymani, Caterina Mezzatesta, Alessandra Pirola, Federica Banfi, Alicia Rubio, Delphine Rea, Fabio Stagno, Emilio Usala, Bruno Martino, Leonardo Campiotti, Michele Me

Concomitant BCORL1 and BRAF Mutations in Vemurafenib-Resistant Melanoma Cells

维莫非尼耐药黑色素瘤细胞中同时发生的 BCORL1 和 BRAF 突变

Luca Mologni, Mariantonia Costanza, Geeta Geeta Sharma, Michela Viltadi, Luca Massimino, Stefania Citterio, Stefania Purgante, Hima Raman, Alessandra Pirola, Massimo Zucchetti, Rocco Piazza, Carlo Gambacorti-Passerini

Synergistic activity of ALK and mTOR inhibitors for the treatment of NPM-ALK positive lymphoma

ALK 和 mTOR 抑制剂对 NPM-ALK 阳性淋巴瘤的协同治疗作用

Sara Redaelli, Monica Ceccon, Laura Antolini, Roberta Rigolio, Alessandra Pirola, Marco Peronaci, Carlo Gambacorti-Passerini, Luca Mologni

BCR/ABL1 and BCR are under the transcriptional control of the MYC oncogene

BCR/ABL1 和 BCR 受 MYC 致癌基因的转录控制

Nitesh Sharma, Vera Magistroni, Rocco Piazza, Stefania Citterio, Caterina Mezzatesta, Praveen Khandelwal, Alessandra Pirola, Carlo Gambacorti-Passerini

NPM/ALK mutants resistant to ASP3026 display variable sensitivity to alternative ALK inhibitors but succumb to the novel compound PF-06463922

对 ASP3026 具有抗性的 NPM/ALK 突变体对替代 ALK 抑制剂表现出不同的敏感性,但对新型化合物 PF-06463922 却毫无抵抗力

Luca Mologni, Monica Ceccon, Alessandra Pirola, Gianpaolo Chiriano, Rocco Piazza, Leonardo Scapozza, Carlo Gambacorti-Passerini

Recurrent SETBP1 mutations in atypical chronic myeloid leukemia

非典型慢性粒细胞白血病中的复发性 SETBP1 突变

Rocco Piazza, Simona Valletta, Nils Winkelmann, Sara Redaelli, Roberta Spinelli, Alessandra Pirola, Laura Antolini, Luca Mologni, Carla Donadoni, Elli Papaemmanuil, Susanne Schnittger, Dong-Wook Kim, Jacqueline Boultwood, Fabio Rossi, Giuseppe Gaipa, Greta P De Martini, Paola Francia di Celle, Hyun